22 May 2013
Keywords: norvasc, combi, therapy, hypertension, drug, giant, pfizer
Article | 20 December 2004
US drug giant Pfizer says that a landmark hypertension trial has been halted early by the study's steering committee because ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 December 2004
13 December 2004
21 May 2013
© 2013 thepharmaletter.com